Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1993 Dec;48(12):1261–1263. doi: 10.1136/thx.48.12.1261

Chlamydia pneumoniae seroprevalence in immunocompetent and immunocompromised populations in Milan.

F Blasi 1, R Cosentini 1, M C Schoeller 1, A Lupo 1, L Allegra 1
PMCID: PMC464989  PMID: 8303635

Abstract

BACKGROUND--Chlamydia pneumoniae is drawing increasing attention as an agent of respiratory tract infection. Specific antibody prevalence in western countries is low in preschool children and reaches more than 50% in adults. However, little is known about the prevalence of this infection in immunocompromised subjects such as HIV-I infected patients. The aim of this study was to evaluate the seroprevalence of Chl pneumoniae in immunocompetent and immunocompromised (HIV-1 infected) paediatric and adult populations. METHODS--Between March 1991 and September 1992 764 healthy subjects (421 men and 343 women, age range six months-81 years), 96 HIV-I infected (73 men and 23 women, age range 18-35 years) and 126 HIV-I negative intravenous drug users (92 men and 34 women, age range 18-37 years), and 50 children (23 boys and 27 girls, age range 8-123 months) with vertically transmitted HIV-I infection were studied. For each subject an HIV-I test (ELISA and Western blot) was performed, together with a microimmunofluorescence test for IgG and IgM antibodies to Chl pneumoniae specific antigen (TW-183). RESULTS--In the healthy population a low prevalence (11%) was observed in children under 10 years of age, which increased progressively to 58% in adults over 70 years. In the HIV-I infected population Chl pneumoniae seroprevalence was higher than in immunocompetent controls (children, 26% v 11%; drug users, 60% v 40%). Moreover, in drug users this difference was also observed in comparison with HIV-1 negative intravenous drug users (60% v 33%). CONCLUSIONS--Our data on Chl pneumoniae seroprevalence in a healthy population are consistent with those reported by others in western countries. Moreover, HIV-I infected subjects seem to be at higher risk of developing Chl pneumoniae infections.

Full text

PDF
1261

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almirall J., Morató I., Riera F., Verdaguer A., Priu R., Coll P., Vidal J., Murgui L., Valls F., Catalan F. Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study. Eur Respir J. 1993 Jan;6(1):14–18. [PubMed] [Google Scholar]
  2. Augenbraun M. H., Roblin P. M., Chirgwin K., Landman D., Hammerschlag M. R. Isolation of Chlamydia pneumoniae from the lungs of patients infected with the human immunodeficiency virus. J Clin Microbiol. 1991 Feb;29(2):401–402. doi: 10.1128/jcm.29.2.401-402.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blasi F., Legnani D., Lombardo V. M., Negretto G. G., Magliano E., Pozzoli R., Chiodo F., Fasoli A., Allegra L. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J. 1993 Jan;6(1):19–22. [PubMed] [Google Scholar]
  4. Clark R., Mushatt D., Fazal B. Case report: Chlamydia pneumoniae pneumonia in an HIV-infected man. Am J Med Sci. 1991 Sep;302(3):155–156. doi: 10.1097/00000441-199109000-00007. [DOI] [PubMed] [Google Scholar]
  5. Grayston J. T., Campbell L. A., Kuo C. C., Mordhorst C. H., Saikku P., Thom D. H., Wang S. P. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis. 1990 Apr;161(4):618–625. doi: 10.1093/infdis/161.4.618. [DOI] [PubMed] [Google Scholar]
  6. Grayston J. T., Kuo C. C., Wang S. P., Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med. 1986 Jul 17;315(3):161–168. doi: 10.1056/NEJM198607173150305. [DOI] [PubMed] [Google Scholar]
  7. Thom D. H., Grayston J. T. Infections with Chlamydia pneumoniae strain TWAR. Clin Chest Med. 1991 Jun;12(2):245–256. [PubMed] [Google Scholar]
  8. Thom D. H., Grayston J. T., Wang S. P., Kuo C. C., Altman J. Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population. Am J Epidemiol. 1990 Aug;132(2):248–256. doi: 10.1093/oxfordjournals.aje.a115654. [DOI] [PubMed] [Google Scholar]
  9. Wang S. P., Grayston J. T. Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol. 1970 Sep;70(3):367–374. doi: 10.1016/0002-9394(70)90096-6. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES